Synthetic Patients: The Future of Clinical Trials?
Join us in this podcast episode, exploring with Prof Matteo Della Porta (Humanitas Research Hospital, Milano, Italy) the emerging role of "synthetic patients" in hematological clinical trials. Innovative generative artificial intelligence models allow today to create synthetic data set based on real patients, suitable to be used as control groups in clinical trials, helping in the identification of disease mechanisms and improving the prognostic risk prediction.
Prof Della Porta will dig into the challenges and opportunities linked to these new technologies, from the overcoming of privacy…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.